MRC Centre for Global Infectious Disease Analysis, School of Public Health, Imperial College London, London W2 1PG, UK.
Department of Biointeractions and Crop Protection, Rothamsted Research, Harpenden AL5 2JQ, UK.
Science. 2018 May 18;360(6390):739-742. doi: 10.1126/science.aap7999.
The recent rate of emergence of pathogenic fungi that are resistant to the limited number of commonly used antifungal agents is unprecedented. The azoles, for example, are used not only for human and animal health care and crop protection but also in antifouling coatings and timber preservation. The ubiquity and multiple uses of azoles have hastened the independent evolution of resistance in many environments. One consequence is an increasing risk in human health care from naturally occurring opportunistic fungal pathogens that have acquired resistance to this broad class of chemicals. To avoid a global collapse in our ability to control fungal infections and to avoid critical failures in medicine and food security, we must improve our stewardship of extant chemicals, promote new antifungal discovery, and leverage emerging technologies for alternative solutions.
近年来,致病性真菌对抗生素的耐药性不断增强,这种情况前所未有。例如,唑类药物不仅用于人类和动物的保健、作物保护,还用于防污涂料和木材保护。唑类药物的广泛应用和多种用途加速了许多环境中耐药性的独立进化。其结果之一是,由于自然发生的机会性真菌病原体对这类广泛的化学物质产生了耐药性,人类保健方面的风险不断增加。为避免我们控制真菌感染的能力全面崩溃,避免医药和粮食安全方面的重大失误,我们必须加强对现有化学品的管理,推动新的抗真菌药物研发,并利用新兴技术寻找替代解决方案。